{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:38:17Z","timestamp":1788406697644,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Impedimed"},{"name":"medi"},{"DOI":"10.13039\/100000098","name":"Clinical Center","doi-asserted-by":"publisher","award":["NIH\/CATS UL1 TR000445"],"award-info":[{"award-number":["NIH\/CATS UL1 TR000445"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1245\/s10434-024-15706-x","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T14:11:05Z","timestamp":1720102265000},"page":"7487-7495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Timing of Breast Cancer Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure"],"prefix":"10.1245","volume":"31","author":[{"given":"Chirag","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Boyages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Koelmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"15706_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fonc.2018.00197","volume":"8","author":"PW Whitworth","year":"2018","unstructured":"Whitworth PW, Shah C, Vicini F, Cooper A. Preventing breast cancer-related lymphedema in high-risk patients: the impact of a structured surveillance protocol using bioimpedance spectroscopy. Front Oncol. 2018;8:197.","journal-title":"Front. Oncol."},{"key":"15706_CR2","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1089\/lrb.2021.0084","volume":"20","author":"SH Ridner","year":"2022","unstructured":"Ridner SH, Dietrich MS, Boyages J, et al. A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphat Res Biol. 2022;20:618\u201328.","journal-title":"Lymphat Res Biol."},{"key":"15706_CR3","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809\u201319.","journal-title":"Cancer."},{"key":"15706_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/lrb.2014.0035","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection: a prospective observational study. Lymphat Res Biol. 2014;12:289\u201394.","journal-title":"Lymphat Res Biol."},{"issue":"18","key":"15706_CR5","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1002\/cncr.34377","volume":"128","author":"LA Koelmeyer","year":"2020","unstructured":"Koelmeyer LA, Gaitatzis K, Dietrich MS, et al. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer. 2020;128(18):3408\u201315.","journal-title":"Cancer."},{"key":"15706_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1200\/OP.23.00060","volume":"19","author":"John Boyages","year":"2023","unstructured":"Boyages John, et al. Axillary treatment and chronic breast cancer\u2013related lymphedema: implications for prospective surveillance and intervention from a randomized controlled trial. JCO Oncol Pract. 2023;19:1116\u201324.","journal-title":"JCO Oncol Pract."},{"issue":"6","key":"15706_CR7","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cam4.691","volume":"5","author":"C Shah","year":"2016","unstructured":"Shah C, Arthur DW, Wazer D, Khan A, Ridner S, Vicini F. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review. Cancer Med. 2016;5(6):1154\u201362.","journal-title":"Cancer Med."},{"key":"15706_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/lrb.2017.0078","volume":"16","author":"F Vicini","year":"2018","unstructured":"Vicini F, Shah C, Whitworth P, et al. Correlation of bioimpedance spectroscopy with risk factors for the development of breast cancer-related lymphedema. Lymphat Res Biol. 2018;16:533\u20137.","journal-title":"Lymphat Res Biol."},{"key":"15706_CR9","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer (Version 2.2024) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"key":"15706_CR10","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Survivorship (Version 1.2024) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/survivorship.pdf"},{"key":"15706_CR11","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34:2\u201311.","journal-title":"Lymphology."},{"key":"15706_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fonc.2016.00192","volume":"6","author":"A Laidley","year":"2016","unstructured":"Laidley A, Anglin B. The impact of L-Dex measurements in assessing breast cancer related lymphedema (BCRL) as part of routine clinical practice. Front Oncol. 2016;6:192.","journal-title":"Front Oncol."},{"issue":"1","key":"15706_CR13","first-page":"344","volume":"18","author":"P Whitworth","year":"2022","unstructured":"Whitworth P, Vicini F, Valente SA, et al. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data. J Cancer Surviv. 2022;18(1):344\u201351.","journal-title":"J Cancer Surviv."},{"issue":"Suppl (3)","key":"15706_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1245\/s10434-015-4683-0","volume":"22","author":"AV Barrio","year":"2015","unstructured":"Barrio AV, Eaton A, Frazier TG. A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema. Ann Surg Oncol. 2015;22(Suppl (3)):370\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"15706_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4274\/ejbh.galenos.2024.2023-12-8","volume":"20","author":"LC Ward","year":"2024","unstructured":"Ward LC, Thompson B, Gaitatzis K, Koelmeyer LA. Comparison of volume measurements and bioimpedance spectroscopy using a stand-on device for assessment of unilateral breast cancer-related lymphedema. Eur J Breast Health. 2024;20(2):141\u20138.","journal-title":"Eur J Breast Health."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15706-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15706-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T08:03:35Z","timestamp":1728029015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15706-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15706"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15706-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chirag Shah, MD received consulting fees from and was on the advisory board of ImpediMed, PreludeDx, and Videra Surgical. John Boyages, MD, PhD has stocks in ImpediMed. Louise Koelmeyer, PhD, BAppSc(OT) received consulting fees from and was on the advisory board of ImpediMed. Steven L. Chen, MD, MBA is an employee of ImpediMed. Frank Vicini received consulting fees from and was on the advisory board of ImpediMed and PreludeDx.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}